title: The Role of miRNAs as Key Regulators in the Neoplastic Microenvironment.
abstract: The neoplastic microenvironment has been recognized to play a critical role in the development of cancer. Although a large body of evidence has established the importance of the cancer microenvironment, the manners of crosstalk between it and the cancer cells still remains unclear. Emerging mechanisms of communication include microRNAs (miRNAs). miRNAs are small noncoding RNA molecules that are involved in the posttranscriptional regulation of mRNA. Both intracellular and circulating miRNAs are differentially expressed in cancer and some of these alterations have been correlated with clinical patient outcomes. The role of miRNAs in the tumor microenvironment has only recently become a focus of research, however. In this paper, we discuss the influence of miRNAs on the tumor microenvironment as it relates to cancer progression. We conclude that miRNAs are a critical component in understanding invasion and metastasis of cancer cells.
authors.affiliation: Biological, Chemical and Physical Sciences Department, College of Arts and Sciences, Roosevelt University, Chicago, IL 60605, USA.
authors.forename: K K
authors.initials: KK
authors.lastname: Wentz-Hunter
authors.forename: J A
authors.initials: JA
authors.lastname: Potashkin
references.citation: Cell. 2005 Dec 16;123(6):1001-11
references.pmid: 16360031
references.citation: J Mol Med (Berl). 2010 Nov;88(11):1085-94
references.pmid: 20614100
references.citation: Proc Natl Acad Sci U S A. 2010 May 4;107(18):8231-6
references.pmid: 20406904
references.citation: Curr Top Microbiol Immunol. 2010;345:31-45
references.pmid: 20517716
references.citation: Nat Rev Genet. 2010 Sep;11(9):597-610
references.pmid: 20661255
references.citation: Cell Cycle. 2007 Jun 15;6(12):1426-31
references.pmid: 17582223
references.citation: J Exp Clin Cancer Res. 2010 Mar 27;29:29
references.pmid: 20346171
references.citation: PLoS One. 2006 Dec 27;1:e116
references.pmid: 17205120
references.citation: Cancer Res. 2005 Jul 15;65(14):6029-33
references.pmid: 16024602
references.citation: Nat Genet. 2008 May;40(5):650-5
references.pmid: 18408720
references.citation: Nat Struct Mol Biol. 2006 Dec;13(12):1097-101
references.pmid: 17099701
references.citation: Exp Hematol. 2009 Feb;37(2):245-55
references.pmid: 19135902
references.citation: Oncogene. 2010 Feb 18;29(7):1073-84
references.pmid: 19915607
references.citation: Curr Mol Pharmacol. 2009 Nov;2(3):263-84
references.pmid: 20021464
references.citation: Diabetes. 2010 Jul;59(7):1794-802
references.pmid: 20393144
references.citation: J Clin Oncol. 2010 Sep 10;28(26):4022-8
references.pmid: 20644094
references.citation: Int J Cancer. 2009 Jul 15;125(2):345-52
references.pmid: 19378336
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5874-8
references.pmid: 18390668
references.citation: Cell Cycle. 2010 Nov 1;9(21):4387-98
references.pmid: 20980827
references.citation: J Gastroenterol Hepatol. 2009 Apr;24(4):652-7
references.pmid: 19175831
references.citation: Nat Genet. 2003 Jan;33(1):49-54
references.pmid: 12469122
references.citation: Mol Cancer. 2007 Jan 14;6:5
references.pmid: 17222355
references.citation: Hepatology. 2010 Mar;51(3):836-45
references.pmid: 20041405
references.citation: Mol Cell. 2009 Sep 24;35(6):737-8
references.pmid: 19782023
references.citation: Cancer Treat Rev. 2008 Apr;34(2):122-36
references.pmid: 18162327
references.citation: Mol Hum Reprod. 2007 Apr;13(4):273-9
references.pmid: 17327266
references.citation: Brain Res. 2009 May 7;1269:158-65
references.pmid: 19265686
references.citation: Cancer Cell. 2004 Jul;6(1):17-32
references.pmid: 15261139
references.citation: Biochem J. 1996 Aug 1;317 ( Pt 3):763-9
references.pmid: 8760360
references.citation: Int J Oncol. 2009 Apr;34(4):1069-75
references.pmid: 19287964
references.citation: Mol Cell. 2010 May 14;38(3):323-32
references.pmid: 20471939
references.citation: Mol Cancer. 2006 Jul 19;5:29
references.pmid: 16854228
references.citation: Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9
references.pmid: 20308559
references.citation: Nat Rev Cancer. 2002 Jan;2(1):38-47
references.pmid: 11902584
references.citation: Cancer. 2000 May 1;88(9):2072-81
references.pmid: 10813719
references.citation: Methods. 2010 Apr;50(4):244-9
references.pmid: 20109550
references.citation: Cancer. 2010 May 1;116(9):2148-58
references.pmid: 20187102
references.citation: Transl Oncol. 2010 Apr;3(2):109-13
references.pmid: 20360935
references.citation: J Cell Physiol. 2010 Jul;224(1):242-9
references.pmid: 20232316
references.citation: Hepatology. 2009 May;49(5):1595-601
references.pmid: 19296468
references.citation: RNA. 2008 Nov;14(11):2348-60
references.pmid: 18812439
references.citation: Oncogene. 2010 Jul 29;29(30):4362-8
references.pmid: 20498629
references.citation: Oncology. 2007;72(5-6):397-402
references.pmid: 18196926
references.citation: Mol Cell Biol. 2007 Mar;27(5):1859-67
references.pmid: 17194750
references.citation: Blood. 2009 May 28;113(22):5588-98
references.pmid: 19182206
references.citation: Int J Cancer. 2009 May 1;124(9):2236-42
references.pmid: 19127597
references.citation: Curr Opin Genet Dev. 2007 Feb;17(1):71-7
references.pmid: 17208433
references.citation: Cell. 2009 Aug 7;138(3):592-603
references.pmid: 19665978
references.citation: Cell Death Differ. 2011 Mar;18(3):465-78
references.pmid: 20885442
references.citation: J Biochem. 2010 Oct;148(4):381-92
references.pmid: 20833630
references.citation: J Thorac Oncol. 2011 Jan;6(1):209-17
references.pmid: 21107292
references.citation: Neuro Oncol. 2005 Apr;7(2):134-53
references.pmid: 15831232
references.citation: Cancer Res. 2009 Feb 1;69(3):1221-9
references.pmid: 19141645
references.citation: Methods. 2010 Apr;50(4):262-70
references.pmid: 20060046
references.citation: Dis Markers. 2009;26(1):27-34
references.pmid: 19242066
references.citation: EMBO J. 2004 Oct 13;23(20):4051-60
references.pmid: 15372072
references.citation: Genes Dev. 2010 Jun 1;24(11):1086-92
references.pmid: 20516194
references.citation: Nat Genet. 2002 Nov;32(3):355-7
references.pmid: 12379854
references.citation: Cancer Res. 2008 Aug 1;68(15):6416-24
references.pmid: 18676867
references.citation: Breast Cancer Res. 2010;12(6):R94
references.pmid: 21067584
references.citation: Cancer Res. 2004 Oct 15;64(20):7231-6
references.pmid: 15492239
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Br J Cancer. 2010 Mar 2;102(5):883-91
references.pmid: 20160723
references.citation: BMC Med. 2010 Oct 21;8:64
references.pmid: 20964835
references.citation: Mol Cell. 2009 Sep 24;35(6):856-67
references.pmid: 19782034
references.citation: Breast Cancer Res Treat. 2009 Sep;117(1):131-40
references.pmid: 18932017
references.citation: J Cancer Res Clin Oncol. 2011 May;137(5):751-9
references.pmid: 20607552
references.citation: PLoS One. 2009 Oct 29;4(10):e7629
references.pmid: 19893619
references.citation: Cell. 2009 Jun 12;137(6):1032-46
references.pmid: 19524507
references.citation: Mol Cell Biol. 2008 Sep;28(17):5369-80
references.pmid: 18591254
references.citation: Clin Cancer Res. 2008 May 1;14(9):2588-92
references.pmid: 18451220
references.citation: Pancreatology. 2009;9(3):293-301
references.pmid: 19407485